| http://www.w3.org/ns/prov#value | - Participants discussed the practical and ethical limitations of conducting clinical trials for MCMs (in both the general population and in at-risk groups such as children2 and pregnant women), and the available alternative regulatory mechanisms to demonstrate efficacy.
|
